Cargando…
Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients
OBJECTIVE: Although the clinical manifestation and risk factors of cerebral microangiopathy (CM) remain unclear, the number of diagnoses is increasing. Hence, patterns of association among lesion topography and severity, clinical symptoms and demographic and disease risk factors were investigated re...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564848/ https://www.ncbi.nlm.nih.gov/pubmed/23393549 http://dx.doi.org/10.1371/journal.pone.0053455 |
_version_ | 1782258369976860672 |
---|---|
author | Okroglic, Sandra Widmann, Catherine N. Urbach, Horst Scheltens, Philip Heneka, Michael T. |
author_facet | Okroglic, Sandra Widmann, Catherine N. Urbach, Horst Scheltens, Philip Heneka, Michael T. |
author_sort | Okroglic, Sandra |
collection | PubMed |
description | OBJECTIVE: Although the clinical manifestation and risk factors of cerebral microangiopathy (CM) remain unclear, the number of diagnoses is increasing. Hence, patterns of association among lesion topography and severity, clinical symptoms and demographic and disease risk factors were investigated retrospectively in a cohort of CM patients. METHODS: Patients treated at the Department of Neurology, University of Bonn for CM (n = 223; 98m, 125f; aged 77.32±9.09) from 2005 to 2010 were retrospectively enrolled. Clinical symptoms, blood chemistry, potential risk factors, demographic data and ratings of vascular pathology in the brain based on the Wahlund scale were analyzed using Pearson's chi square test and one-way ANOVA. RESULTS: Progressive cognitive decline (38.1%), gait apraxia (27.8%), stroke-related symptoms and seizures (24.2%), TIA-symptoms (22%) and vertigo (17%) were frequent symptoms within the study population. Frontal lobe WMLs/lacunar infarcts led to more frequent presentation of progressive cognitive decline, seizures, gait apraxia, stroke-related symptoms, TIA, vertigo and incontinence. Parietooccipital WMLs/lacunar infarcts were related to higher frequencies of TIA, seizures and incontinence. Basal ganglia WMLs/lacunar infarcts were seen in patients with more complaints of gait apraxia, vertigo and incontinence. Age (p = .012), arterial hypertension (p<.000), obesity (p<.000) and cerebral macroangiopathy (p = .018) were positively related to cerebral lesion load. For increased glucose level, homocysteine, CRP and D-Dimers there was no association. CONCLUSION: This underlines the association of CM with neurological symptoms upon admission in a topographical manner. Seizures and vertigo are symptoms of CM which may have been missed in previous studies. In addition to confirming known risk factors such as aging and arterial hypertension, obesity appears to increase the risk as well. Since the incidence of CM is increasing, future studies should focus on the importance of prevention of vascular risk factors on its pathogenesis. |
format | Online Article Text |
id | pubmed-3564848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35648482013-02-07 Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients Okroglic, Sandra Widmann, Catherine N. Urbach, Horst Scheltens, Philip Heneka, Michael T. PLoS One Research Article OBJECTIVE: Although the clinical manifestation and risk factors of cerebral microangiopathy (CM) remain unclear, the number of diagnoses is increasing. Hence, patterns of association among lesion topography and severity, clinical symptoms and demographic and disease risk factors were investigated retrospectively in a cohort of CM patients. METHODS: Patients treated at the Department of Neurology, University of Bonn for CM (n = 223; 98m, 125f; aged 77.32±9.09) from 2005 to 2010 were retrospectively enrolled. Clinical symptoms, blood chemistry, potential risk factors, demographic data and ratings of vascular pathology in the brain based on the Wahlund scale were analyzed using Pearson's chi square test and one-way ANOVA. RESULTS: Progressive cognitive decline (38.1%), gait apraxia (27.8%), stroke-related symptoms and seizures (24.2%), TIA-symptoms (22%) and vertigo (17%) were frequent symptoms within the study population. Frontal lobe WMLs/lacunar infarcts led to more frequent presentation of progressive cognitive decline, seizures, gait apraxia, stroke-related symptoms, TIA, vertigo and incontinence. Parietooccipital WMLs/lacunar infarcts were related to higher frequencies of TIA, seizures and incontinence. Basal ganglia WMLs/lacunar infarcts were seen in patients with more complaints of gait apraxia, vertigo and incontinence. Age (p = .012), arterial hypertension (p<.000), obesity (p<.000) and cerebral macroangiopathy (p = .018) were positively related to cerebral lesion load. For increased glucose level, homocysteine, CRP and D-Dimers there was no association. CONCLUSION: This underlines the association of CM with neurological symptoms upon admission in a topographical manner. Seizures and vertigo are symptoms of CM which may have been missed in previous studies. In addition to confirming known risk factors such as aging and arterial hypertension, obesity appears to increase the risk as well. Since the incidence of CM is increasing, future studies should focus on the importance of prevention of vascular risk factors on its pathogenesis. Public Library of Science 2013-02-05 /pmc/articles/PMC3564848/ /pubmed/23393549 http://dx.doi.org/10.1371/journal.pone.0053455 Text en © 2013 Okroglic et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Okroglic, Sandra Widmann, Catherine N. Urbach, Horst Scheltens, Philip Heneka, Michael T. Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients |
title | Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients |
title_full | Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients |
title_fullStr | Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients |
title_full_unstemmed | Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients |
title_short | Clinical Symptoms and Risk Factors in Cerebral Microangiopathy Patients |
title_sort | clinical symptoms and risk factors in cerebral microangiopathy patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564848/ https://www.ncbi.nlm.nih.gov/pubmed/23393549 http://dx.doi.org/10.1371/journal.pone.0053455 |
work_keys_str_mv | AT okroglicsandra clinicalsymptomsandriskfactorsincerebralmicroangiopathypatients AT widmanncatherinen clinicalsymptomsandriskfactorsincerebralmicroangiopathypatients AT urbachhorst clinicalsymptomsandriskfactorsincerebralmicroangiopathypatients AT scheltensphilip clinicalsymptomsandriskfactorsincerebralmicroangiopathypatients AT henekamichaelt clinicalsymptomsandriskfactorsincerebralmicroangiopathypatients |